Spinner CD, Felizarta F, Rizzardini G, Philibert P, et al. Phase IIa Proof-of-Concept Evaluation of the Antiviral Efficacy, Safety, Tolerability, and Pharmacokinetics of the Next-Generation Maturation Inhibitor GSK3640254. Clin Infect Dis 2022 Jan 6. pii: 6498296. doi: 10.1093/cid/ciab1065.
PMID: 34996113